Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Christine E, Koval"'
Publikováno v:
American Journal of Transplantation. 22:2903-2911
Emerging data support the safety of transplantation of extra-pulmonary organs from donors with SARS-CoV-2-detection. Our center offered kidney transplantation (KT) from deceased donors (DD) with SARS-CoV-2 with and without COVID-19 as a cause of deat
Publikováno v:
American Journal of Transplantation. 22:2217-2227
Coronavirus disease-19 has had a marked impact on the transplant population and processes of care for transplant centers and organ allocation. Several single-center studies have reported successful utilization of deceased donors with positive severe
Autor:
Sonya M. Kothadia, Christine E. Koval
Publikováno v:
Transplant Infectious Disease. 25
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 21(11)
Transplantation of solid organs from donors with active SARS-CoV-2 infection has been advised against due to the possibility of disease transmission to the recipient. However, with the exception of lungs, conclusive data for productive infection of t
Publikováno v:
Annals of the American Thoracic Society. 16:626-630
Autor:
James K. Kirklin, Theo M M H de By, Rongbing Xie, Stephan Schueler, Vivian H. Chu, Christine E. Koval, Jennifer A Cowger, Margaret M. Hannan, Takeshi Nakatani, Anne I. Dipchand, Christopher S. Hayward, Ryan S. Cantor, Thomas Krabatsch
Publikováno v:
The Journal of Heart and Lung Transplantation. 38:364-373
BACKGROUND Despite advances in device technology and treatment strategies, infection remains a major cause of adverse events (AEs) in mechanical circulatory support (MCS) patients. To characterize the epidemiology of MCS infection, we examined the ty
Publikováno v:
Transplant Infectious Disease. 23
Background Trimethoprim-sulfamethoxazole (TMP-SMX) is the drug of choice for Pneumocystis jirovecii pneumonia (PJP) prophylaxis and has activity against other opportunistic infections (OIs) after solid organ transplant (SOT). We aimed to describe the
Autor:
Francisco Marco Canosa, Cassandra Calabrese, K. V. Narayanan Menon, Emilio D. Poggio, Christine E. Koval, Marie Budev, Tannaz Asadi, Prabalini Rajendram, Jose A Morillas, Brian R. Gastman, Pavithra Srinivas
Publikováno v:
American Journal of Transplantation
There are emerging data depicting the clinical presentation of coronavirus disease 19 (COVID-19) in solid organ transplant recipients but negligible data-driven guidance on clinical management. A biphasic course has been described in some infected wi
Autor:
K. V. Narayanan Menon, Charles Miller, Jamak Modaresi Esfeh, Bijan Eghtesad, Christine E. Koval, Alan J. Taege, Cristiano Quintini, Anita R Modi
Publikováno v:
Transplant Infectious Disease
Coronavirus disease 2019 (COVID‐19), mediated by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), can manifest with flu‐like illness and severe pneumonia with acute respiratory distress syndrome (ARDS). Immunocompromised patients
Publikováno v:
Cleveland Clinic Journal of Medicine.
Drugs targeting RNA respiratory viruses have resulted in few effective therapies, highlighting challenges for antivirals to treat COVID-19. Several antivirals are being investigated for symptomatic COVID-19 but no definitive data support their clinic